Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Hormonal Regulation and Hypertension, Eicosanoids and Hypertension Pharmacology, Heart Failure Treatment and Management, and Adrenal Hormones and Disorders.
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus Document